PremiumCompany AnnouncementsLivzon Pharmaceutical Group Strengthens LivzonBio with Capital Contribution Livzon Pharmaceutical Concludes Share Options Cancellation Livzon Pharmaceutical Group Reports Q1 2025 Earnings PremiumCompany AnnouncementsLivzon Pharmaceutical Updates Final Dividend Details for 2024 Livzon Pharmaceutical Announces Executive Resignation Livzon Pharmaceutical Appoints New Vice President for Production Operations PremiumCompany AnnouncementsLivzon Pharmaceutical Group Reports Steady Profit Growth Livzon Pharmaceutical Group Announces 2024 Audited Financial Results Livzon Pharmaceutical Increases Stake in LivzonBio with RMB1 Billion Investment